Reported covered position: 2015-2017: Senior Policy Advisor, Rep. Jan Schakowsky; 2013-2015: Senior Legislative Assistance, Rep. Bill Foster; 2009-2013: Legislative Assistant, Staff Assistant, Rep. Maurice Hinchey
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Source: Senate LDA
| CONSUMER TECHNOLOGY ASSOCIATION |
| 12 |
| 2024–2026 |
| MAIMONIDES MEDICAL CENTER | 11 | 2022–2024 |
| ADVOCATE AURORA HEALTHCARE | 10 | 2022–2024 |
| PREVENTIVE MEDICINE RESEARCH INSTITUTE | 9 | 2021–2023 |
| POINT OF CARE TESTING ASSOCIATION | 8 | 2021–2023 |
| TESTING AT HOME COALITION FKA AT-HOME COVID TESTING (ACT) COALITION | 8 | 2021–2023 |
| AMERICA'S ESSENTIAL HOSPITALS | 7 | 2021–2023 |
| AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION | 7 | 2023–2024 |
| ELLUME HEALTH | 7 | 2022–2023 |
| HIGH-THROUGHPUT DIAGNOSTIC TESTING COALITION | 4 | 2021–2022 |
| NATIONAL ACADEMY OF ELDER LAW ATTORNEYS | 4 | 2026 |
| HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION | 1 | 2026 |
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding
Access to Inpatient Rehabilitation Therapy Act of 2023
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Access to Inpatient Rehabilitation Therapy Act of 2023
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Access to Inpatient Rehabilitation Therapy Act of 2023
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Access to Inpatient Rehabilitation Therapy Act of 2023
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Access to Inpatient Rehabilitation Therapy Act of 2023
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Access to Inpatient Rehabilitation Therapy Act of 2023
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Access to Inpatient Rehabilitation Therapy Act of 2023
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Access to Inpatient Rehabilitation Therapy Act of 2023
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION · Firm: MCDERMOTT+ LLC
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Medicare payment for clinical laboratory services and implementation of Section 216 of the Protecting Access to Medicare Act of 2014, including H.R.2377 and S.1000.
Medicare payment for clinical laboratory services and implementation of Section 216 of the Protecting Access to Medicare Act of 2014, including H.R.2377 and S.1000.
Medicare payment for clinical laboratory services and implementation of Section 216 of the Protecting Access to Medicare Act of 2014, including H.R.2377 and S.1000.
Chesapeake Bay Accountability and Recovery Act of 2014
Client: POINT OF CARE TESTING ASSOCIATION · Firm: MCDERMOTT+ LLC
Medicare payment for clinical laboratory services and implementation of Section 216 of the Protecting Access to Medicare Act of 2014, including H.R.2377 and S.1000.
Chesapeake Bay Accountability and Recovery Act of 2014
Client: POINT OF CARE TESTING ASSOCIATION · Firm: MCDERMOTT+ LLC
Medicare payment for clinical laboratory services and implementation of Section 216 of the Protecting Access to Medicare Act of 2014, including H.R.2377 and S.1000.
Chesapeake Bay Accountability and Recovery Act of 2014
Client: POINT OF CARE TESTING ASSOCIATION · Firm: MCDERMOTT+ LLC
Medicare payment for clinical laboratory services and implementation of Section 216 of the Protecting Access to Medicare Act of 2014, including H.R.2377 and S.1000.
Examining Opioid Treatment Infrastructure Act of 2021
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to Build Back Better legislation.
Examining Opioid Treatment Infrastructure Act of 2021
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to Build Back Better legislation.
Infrastructure Investment and Jobs Act
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to Build Back Better legislation.
Infrastructure Investment and Jobs Act
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to Build Back Better legislation.
Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce Health care provisions in budget reconciliation H.R.4390 - PROTECT 340B Act of 2021 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act S.2938 - Bipartisan Safer Communities Act
Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce Health care provisions in budget reconciliation H.R.4390 - PROTECT 340B Act of 2021 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act S.2938 - Bipartisan Safer Communities Act
Access to Prescription Digital Therapeutics Act of 2022
Client: BIG HEALTH INC. · Firm: MCDERMOTT+ LLC
Seeking a new benefit category for digital therapeutics. H.R.7051, Access to Prescription Digital Therapeutics Act of 2022. Mental Health Legislation, including H.R.7666, H.R.7780 and S.4170.
Access to Prescription Digital Therapeutics Act of 2022
Client: BIG HEALTH INC. · Firm: MCDERMOTT+ LLC
Seeking a new benefit category for digital therapeutics. H.R.7051, Access to Prescription Digital Therapeutics Act of 2022.
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce Health care provisions in budget reconciliation H.R.4390 - PROTECT 340B Act of 2021 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act S.2938 - Bipartisan Safer Communities Act
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: BIG HEALTH INC. · Firm: MCDERMOTT+ LLC
Seeking a new benefit category for digital therapeutics. H.R.7051, Access to Prescription Digital Therapeutics Act of 2022. Mental Health Legislation, including H.R.7666, H.R.7780 and S.4170.
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce Health care provisions in budget reconciliation H.R.4390 - PROTECT 340B Act of 2021 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act S.2938 - Bipartisan Safer Communities Act
Seeking a new benefit category for digital therapeutics. H.R.7051, Access to Prescription Digital Therapeutics Act of 2022. Mental Health Legislation, including H.R.7666, H.R.7780 and S.4170.
Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce Health care provisions in budget reconciliation H.R.4390 - PROTECT 340B Act of 2021 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act S.2938 - Bipartisan Safer Communities Act
Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce Health care provisions in budget reconciliation H.R.4390 - PROTECT 340B Act of 2021 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act S.2938 - Bipartisan Safer Communities Act
Mental Health Reform Reauthorization Act of 2022
Client: BIG HEALTH INC. · Firm: MCDERMOTT+ LLC
Seeking a new benefit category for digital therapeutics. H.R.7051, Access to Prescription Digital Therapeutics Act of 2022. Mental Health Legislation, including H.R.7666, H.R.7780 and S.4170.
Examining Opioid Treatment Infrastructure Act of 2021
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to the Bipartisan Infrastructure Framework and Build Back Better legislation.
Examining Opioid Treatment Infrastructure Act of 2021
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to the Bipartisan Infrastructure Framework and Build Back Better legislation.
Examining Opioid Treatment Infrastructure Act of 2021
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to the Bipartisan Infrastructure Framework and Build Back Better legislation.
Examining Opioid Treatment Infrastructure Act of 2021
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to the Bipartisan Infrastructure Framework and Build Back Better legislation.
Infrastructure Investment and Jobs Act
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to the Bipartisan Infrastructure Framework and Build Back Better legislation.
Infrastructure Investment and Jobs Act
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to the Bipartisan Infrastructure Framework and Build Back Better legislation.
Infrastructure Investment and Jobs Act
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to the Bipartisan Infrastructure Framework and Build Back Better legislation.
Infrastructure Investment and Jobs Act
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: MCDERMOTT+ LLC
H.R. 3684, the INVEST in America Act HR 1686, Medicare sequestration delay Issues relating to COVID-19, Medicare, Medicaid, 340B, and health care workforce. Issues relating to the Bipartisan Infrastructure Framework and Build Back Better legislation.
Issues related to Health care, Medicare, Medicaid, and the Older Americans Act.
Issues related to Health care, Medicare, Medicaid and the Older Americans Act.
Issues related to Health care, Medicare, Medicaid and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues related to Health care, Medicare, Medicaid, and the Older Americans Act.
Issues related to Health care, Medicare, Medicaid and the Older Americans Act.
Issues related to Health care, Medicare, Medicaid and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Federal health policies pertaining to the resilience of the health care supply chain and Medicare payment policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues related to Health care, Medicare, Medicaid and the Older Americans Act.
Issues related to Health care, Medicare, Medicaid, and the Older Americans Act.
Issues related to Health care, Medicare, Medicaid and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via MCDERMOTT+ LLC
2026 · first_quarter · RR
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding
NATIONAL COUNCIL ON AGING via MCDERMOTT+
2025 · second_quarter · 2A
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
NATIONAL COUNCIL ON AGING via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIG HEALTH INC. via MCDERMOTT+
2025 · fourth_quarter · Q4
Seeking a new benefit category and reimbursement for digital therapeutics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Q3
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+
2025 · third_quarter · Q3
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · third_quarter · Q3
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+
2025 · third_quarter · Q3
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+
2025 · third_quarter · Q3
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+
2025 · third_quarter · Q3
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIG HEALTH INC. via MCDERMOTT+
2025 · third_quarter · Q3
Seeking a new benefit category and reimbursement for digital therapeutics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+
2025 · second_quarter · Q2
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · second_quarter · Q2
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Q2
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+
2025 · second_quarter · Q2
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+
2025 · second_quarter · Q2
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+
2025 · second_quarter · Q2
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIG HEALTH INC. via MCDERMOTT+
2025 · second_quarter · Q2
Seeking a new benefit category for digital therapeutics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+
2025 · first_quarter · Q1
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+
2025 · first_quarter · Q1
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIG HEALTH INC. via MCDERMOTT+
2025 · first_quarter · Q1
Seeking a new benefit category for digital therapeutics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+
2025 · first_quarter · Q1
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Q1
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+
2025 · first_quarter · Q1
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · first_quarter · Q1
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIG HEALTH INC. via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Seeking a new benefit category for digital therapeutics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION via MCDERMOTT+ LLC
2024 · fourth_quarter · 4T
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · third_quarter · 3A
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAIMONIDES MEDICAL CENTER via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to Medicaid, Medicare, and the healthcare workforce. Issues relating to community project funding.
Issues relating to Medicaid, Medicare, and the health care workforce. Issues relating to community project funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
340B HEALTH via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIG HEALTH INC. via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Seeking a new benefit category for digital therapeutics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIG HEALTH INC. via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Seeking a new benefit category for digital therapeutics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVOCATE AURORA HEALTHCARE via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to hospital reimbursement and regulatory requirements. Issues relevant to inpatient and outpatient hospitals.
Issues relating to hospital reimbursement and regulatory requirements. Issues relevant to inpatient and outpatient hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAIMONIDES MEDICAL CENTER via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to Medicaid, Medicare, and the health care workforce. Issues relating to community project funding.
Issues relating to Medicaid, Medicare, and the healthcare workforce. Issues relating to community project funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to healthcare innovation, including digital health and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAIMONIDES MEDICAL CENTER via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to Medicaid, Medicare, and the healthcare workforce. Issues relating to community project funding.
Issues relating to Medicaid, Medicare, and the health care workforce. Issues relating to community project funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Issues relating to H.R. 6110 Access to Inpatient Rehabilitation Therapy Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVOCATE AURORA HEALTHCARE via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to hospital reimbursement and regulatory requirements. Issues relevant to inpatient and outpatient hospitals.
Issues relating to hospital reimbursement and regulatory requirements. Issues relevant to inpatient and outpatient hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONSUMER TECHNOLOGY ASSOCIATION via MCDERMOTT+ LLC
2024 · first_quarter · RR
Issues relating to healthcare innovation, including digital health and artificial intelligence
340B HEALTH via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAIMONIDES MEDICAL CENTER via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues relating to Medicaid, Medicare, and the health care workforce. Issues relating to community project funding.
Issues relating to Medicaid, Medicare, and the healthcare workforce. Issues relating to community project funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PREVENTIVE MEDICINE RESEARCH INSTITUTE via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Promote legislative and regulatory methods of ensuring that intensive cardiac rehabilitation and cardiac rehabilitation are permanently permitted in Medicare via telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CASTLE BIOSCIENCES, INC. via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues relating to Medicare coverage for laboratory diagnostic services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIG HEALTH INC. via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Seeking a new benefit category for digital therapeutics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2023 · fourth_quarter · RR
Issues relating to utilization of and access to urgent care centers.
AMERICAN MEDICAL REHABILITATION PROVIDER ASSOCIATION via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Issues relating to post-acute care providers and inpatient rehabilitation hospitals. Improving Seniors' Timely Access to Care Act (S. 3018 /H.R. 3173).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADVOCATE AURORA HEALTHCARE via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues relating to hospital reimbursement and regulatory requirements. Issues relevant to inpatient and outpatient hospitals.
Issues relating to hospital reimbursement and regulatory requirements. Issues relevant to inpatient and outpatient hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL COUNCIL ON AGING via MCDERMOTT+ LLC
2023 · third_quarter · Q3
Issues relating to Medicare, Medicaid, and the Older Americans Act.
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
340B HEALTH via MCDERMOTT+ LLC
2023 · third_quarter · Q3
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE